搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Xylella fastidiosa Tryptophan synthase alpha chain (trpA) CSB-YP531688XBM
CSB-EP531688XBM
CSB-BP531688XBM
CSB-MP531688XBM
CSB-EP531688XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa UDP-N-acetylglucosamine 1-carboxyvinyltransferase (murA) CSB-YP531689XBM
CSB-EP531689XBM
CSB-BP531689XBM
CSB-MP531689XBM
CSB-EP531689XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa 50S ribosomal protein L31 type B (rpmE2) CSB-YP531690XBM
CSB-EP531690XBM
CSB-BP531690XBM
CSB-MP531690XBM
CSB-EP531690XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Xylella fastidiosa UPF0149 protein Xfasm12_0965 (Xfasm12_0965) CSB-YP531691XBM
CSB-EP531691XBM
CSB-BP531691XBM
CSB-MP531691XBM
CSB-EP531691XBM-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Molybdenum cofactor biosynthesis protein C (moaC) CSB-YP531692MTE
CSB-EP531692MTE
CSB-BP531692MTE
CSB-MP531692MTE
CSB-EP531692MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Ketol-acid reductoisomerase (ilvC) CSB-YP531693MTE
CSB-EP531693MTE
CSB-BP531693MTE
CSB-MP531693MTE
CSB-EP531693MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP531694MTE
CSB-EP531694MTE
CSB-BP531694MTE
CSB-MP531694MTE
CSB-EP531694MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Nitrogenase-stabilizing/protective protein nifW (nifW) CSB-YP531695MTE
CSB-EP531695MTE
CSB-BP531695MTE
CSB-MP531695MTE
CSB-EP531695MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Urease accessory protein UreG (ureG) CSB-YP531696MTE
CSB-EP531696MTE
CSB-BP531696MTE
CSB-MP531696MTE
CSB-EP531696MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP531697MTE
CSB-EP531697MTE
CSB-BP531697MTE
CSB-MP531697MTE
CSB-EP531697MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Diaminopimelate epimerase (dapF) CSB-YP531698MTE
CSB-EP531698MTE
CSB-BP531698MTE
CSB-MP531698MTE
CSB-EP531698MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. 30S ribosomal protein S2 (rpsB) CSB-YP531699MTE
CSB-EP531699MTE
CSB-BP531699MTE
CSB-MP531699MTE
CSB-EP531699MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. ATP-dependent Clp protease ATP-binding subunit ClpX (clpX) CSB-YP531700MTE
CSB-EP531700MTE
CSB-BP531700MTE
CSB-MP531700MTE
CSB-EP531700MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Light-independent protochlorophyllide reductase subunit B (bchB), partial CSB-YP531701MTE
CSB-EP531701MTE
CSB-BP531701MTE
CSB-MP531701MTE
CSB-EP531701MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. PKHD-type hydroxylase M446_1130 (M446_1130) CSB-YP531702MTE
CSB-EP531702MTE
CSB-BP531702MTE
CSB-MP531702MTE
CSB-EP531702MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. 50S ribosomal protein L33 (rpmG) CSB-YP531703MTE
CSB-EP531703MTE
CSB-BP531703MTE
CSB-MP531703MTE
CSB-EP531703MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Peptidyl-tRNA hydrolase (pth) CSB-YP531704MTE
CSB-EP531704MTE
CSB-BP531704MTE
CSB-MP531704MTE
CSB-EP531704MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. Membrane protein insertase YidC (yidC), partial CSB-YP531705MTE1
CSB-EP531705MTE1
CSB-BP531705MTE1
CSB-MP531705MTE1
CSB-EP531705MTE1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. 30S ribosomal protein S13 (rpsM) CSB-YP531706MTE
CSB-EP531706MTE
CSB-BP531706MTE
CSB-MP531706MTE
CSB-EP531706MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methylobacterium sp. 50S ribosomal protein L16 (rplP) CSB-YP531707MTE
CSB-EP531707MTE
CSB-BP531707MTE
CSB-MP531707MTE
CSB-EP531707MTE-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>